Novavax
NVAX
#5817
Rank
โ‚น97.34 B
Marketcap
โ‚น599.03
Share price
-1.77%
Change (1 day)
-22.16%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: โ‚น97.34 Billion

As of December 2025 Novavax has a market cap of โ‚น97.34 Billion. This makes Novavax the world's 5817th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น97.34 B-14.45%
2024โ‚น113.78 B139.7%
2023โ‚น47.46 B-34.36%
2022โ‚น72.31 B-91.02%
2021โ‚น805.14 B55.09%
2020โ‚น519.15 B5553.97%
2019โ‚น9.18 B-81.44%
2018โ‚น49.46 B66.42%
2017โ‚น29.72 B27.98%
2016โ‚น23.22 B-84.57%
2015โ‚น150.52 B67.7%
2014โ‚น89.76 B36%
2013โ‚น66.00 B331.1%
2012โ‚น15.30 B99.78%
2011โ‚น7.66 B-36.62%
2010โ‚น12.09 B-2.3%
2009โ‚น12.37 B96.94%
2008โ‚น6.28 B-22.39%
2007โ‚น8.09 B-27.85%
2006โ‚น11.22 B18.33%
2005โ‚น9.48 B69.81%
2004โ‚น5.58 B-41.12%
2003โ‚น9.48 B204.61%
2002โ‚น3.11 B-80.35%
2001โ‚น15.84 B80.73%
2000โ‚น8.76 B136.43%
1999โ‚น3.70 B271.02%
1998โ‚น0.99 B-57.65%
1997โ‚น2.36 B79.13%
1996โ‚น1.31 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Novavax was reported to be:

โ‚น97.34 Billion
by Nasdaq info icon info icon
โ‚น97.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
โ‚น11.99 B-87.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น208.95 B 114.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น55.76 B-42.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น144.68 B 48.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น25.049 T 25,632.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น12.953 T 13,207.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.610 T 23,127.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚น2.21 B-97.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.612 T 8,747.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น167.88 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA